| Literature DB >> 34022394 |
Barbara Clyne1, Kieran A Walsh2, Eamon O'Murchu2, Melissa K Sharp3, Laura Comber2, Kirsty K O' Brien2, Susan M Smith3, Patricia Harrington2, Michelle O'Neill2, Conor Teljeur2, Máirín Ryan4.
Abstract
Entities:
Year: 2021 PMID: 34022394 PMCID: PMC8132503 DOI: 10.1016/j.jclinepi.2021.05.010
Source DB: PubMed Journal: J Clin Epidemiol ISSN: 0895-4356 Impact factor: 6.437
Overview of exemplar rapid reviews
| Review | Overview | Would removal of preprints change the findings | Findings unique to preprints |
|---|---|---|---|
| Viral load | Removal of the 17 preprint studies would not change the overall findings of the review. | Two pre-prints that compared viral load and culture positivity between children and adults were the only studies that specifically examined the differences at that time. However, the findings were broadly consistent with what was implied from the included journal articles. | |
| Immunity | Yes. Preprints provided the most recent data on SARS-CoV-2 and even SARS-CoV. Our findings that anti-SARS-CoV-2 antibodies can be detected beyond 60 days post-symptom onset comes from data exclusively derived from preprints. Additionally, IgG seropositivity follow-up beyond 10 years in SARS-CoV studies was also limited to one preprint study. This study detected IgG at 12 years. | Preprints provided the longest follow-up and therefore contributed greatly to the maximum duration of detection of antibody responses. However, the findings relating to reinfection and seroconversion did not differ between preprint and journal articles. | |
| Transmission in Children(28) | Removal of the 7 preprint studies would not change the overall findings of the review. | All 3 modeling studies were preprints. The findings of these studies were consistent with the overall findings, but they were the only papers to use this method. |
Abbreviations: IgG, Immunoglobulin G.
Fig. 1Study design by publication type included in exemplar rapid reviews.
Fig. 2Study methodological quality appraisal by publication type included in exemplar rapid reviews.
Suggestions for including preprints in rapid reviews
| Domain | Suggestions for including preprints |
|---|---|
Review bibliographic databases policies and coverage regarding preprints. | |
Rapid review teams should clearly indicate within their reviews, in the data extraction, written results and table of included studies, where an included study is a preprint. | |
| Reporting quality | We found no evidence to suggest that COVID-19 preprints should be considered less methodologically valid than COVID-19 peer-reviewed studies. Preprint manuscripts may have grammatical and numerical errors and rapid review teams should have a clear protocol in place for dealing with errors such as contradictory results between tables and text. COVID-19 preprints, while a work in progress, should be double checked by the author team for inconsistencies in the reporting of data between tables/figures and text prior to depositing on a preprint server. Authors should include a version control log within the manuscript, highlighting changes between versions. Authors should use an appropriate standardised reporting checklist. |
| Synthesis and interpretation of findings | Rapid review teams should conduct a sensitivity analysis (quantitatively or narratively) to assess the impact of inclusion of preprints on the overall results and conclusions. |
Rapid review teams should have a clear policy around whether they will or will not check peer review status of preprints included in a rapid review, and at what point in the review process this would occur. We suggest that study authors include a statement in the final peer-reviewed version of the manuscript with the citation of the preprint version. | |
| Changes between preprints and peer review publications | Rapid review teams should factor in adequate time and resources in their protocols for any necessary review updates arising from differences between preprints and peer-reviewed manuscripts. If review teams do not plan to cross-check for published peer-reviewed versions, they should explicitly state this. Authors should include a statement in the final peer-reviewed version of any substantial changes to the data or interpretation from the preprint version. |